Home › Cardiovascular Disease › Arizona › Gilbert
Cardiovascular Disease clinical trials in Gilbert, AZ
6 studies for Cardiovascular Disease are looking for participants at sites in and around Gilbert (within about 30 miles). Open a study to see who can join and how to contact the study team.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Gilbert
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Mercy Gilbert Medical Center, Gilbert
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Gilbert
- Research Site, Gilbert
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Recruiting
- Dignity Health - Mercy Gilbert Medical Center, Gilbert
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- Dignity Health - Mercy Gilbert Medical Center, Gilbert
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in Gilbert
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer9 studies
- Breast Cancer9 studies
- Cancer (all types)8 studies
- Lung Cancer8 studies
- Multiple Myeloma6 studies
- Metastatic Cancer6 studies
- Heart Failure6 studies
- Bladder Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Non-Hodgkin Lymphoma5 studies
- Diffuse Large B-Cell Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.